[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"perinatal-problems\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:perinatal-problems":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,45,75],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":5},"100605695","clinical-trial-to-reduce-perinatal-intimate-partner-violence-100605695",false,"NCT07165860","Clinical Trial to Reduce Perinatal Intimate Partner Violence","Novel Doula Intervention to Leverage Clinic-community Connections to Support Perinatal Intimate Partner Violence Survivors","Inclusion Criteria: Perinatal IPV survivors are eligible if they:\n\n* 1\\) feel comfortable completing the study in Spanish or English\n* 2\\) are age 18 or older\n* 3\\) are no more than 24 weeks 6 days gestation (note: participants enrolled earliest at 18 weeks, baseline at 22 weeks with a 3 week window)\n* 4\\) identify as an IPV survivor by answering affirmatively to a definition of experiencing IPV\n* 5\\) live within a 50 mile radius of Pittsburgh, Pennsylvania\n* 6\\) able to provide safe and complete contact information or take a study cell phone\n\nExclusion Criteria:\n\n* Unable to consent\n* Do not meet inclusion criteria\n* Cannot provide safe contact information or take a study cell phone\n* Incarcerated",true,"FEMALE","18 Years",{"count":20,"type":21},250,"ESTIMATED","INTERVENTIONAL",[24],"NA","This is a two-armed, fully powered hybrid type 1 trial to test the effectiveness of a doula intervention compared with an active control in reducing intimate partner violence (IPV) among perinatal IPV survivors",[27,28],"Domestic Violence","Perinatal Problems",[30,31,32],"intimate partner violence","perinatal health","doula","RECRUITING","2026-04-13",{"date":36,"type":37},"2026-04-16","ACTUAL",{"date":39,"type":37},"2025-11-01",{"date":41,"type":21},"2029-05-01",{"name":43,"class":44},"University of Pittsburgh","OTHER",{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":52,"targetDuration":4,"studyType":54,"phases":4,"briefSummary":55,"conditions":56,"keywords":60,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":74},"100614318","trends-in-the-administration-of-tranexamic-acid-for-postpartum-hemorrhage-100614318","NCT07278037","Trends in the Administration of Tranexamic Acid for Postpartum Hemorrhage","A Retrospective Analysis of the Longitudinal Pattern of Tranexamic Acid Administration in Parturients Undergoing Cesarean Delivery Complicated by Postpartum Hemorrhage","Inclusion Criteria:\n\n* 1\\. Patients underwent cesarean delivery with primary postpartum hemorrhage\n\nExclusion Criteria:\n\n1. Gestational age at less than 24 weeks\n2. Absence of the anesthetic record\n3. Received tranexamic acid in the antepartum period\n4. Blood loss less than 1,000 ml",{"count":53,"type":21},648,"OBSERVATIONAL","Postpartum hemorrhage (PPH) is the global leading cause of maternal death, with 20-30% of maternal deaths in Thailand linked to hemorrhage. The WOMAN Trial (2017) provided strong evidence that administering tranexamic acid (TXA)within three hours of bleeding onset lowered PPH-related mortality by 31%. Consequently, the World Health Organization (WHO) updated its guidelines, recommending TXA as part of the standard treatment package for all PPH cases. Following this, the use of TXA has been widely adopted globally and increased in Thailand. A recent study at a major Thai university hospital observed a significant increase in TXA administration after 2017. The current study aims to further analyze the recent growth rate of TXA use and its impact on obstetric and perinatal outcomes during cesarean deliveries with PPH.",[57,58,59,28],"Postpartum Hemorrhage","Delivery Complication","Cesarean Section Complications",[61,62,63,64],"cesarean delivery","complications","postpartum hemorrhage","tranexamic acid","2025-12-16",{"date":67,"type":37},"2025-12-22",{"date":69,"type":37},"2025-12-01",{"date":71,"type":21},"2026-09-30",{"name":73,"class":44},"Mahidol University",1,{"id":76,"slug":77,"hasResults":11,"nctId":78,"briefTitle":79,"officialTitle":79,"acronym":4,"eligibilityCriteria":80,"healthyVolunteers":16,"sex":81,"minAge":82,"maxAge":4,"enrollmentInfo":83,"targetDuration":4,"studyType":22,"phases":85,"briefSummary":86,"conditions":87,"keywords":90,"overallStatus":97,"whyStopped":4,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":101,"completionDateStruct":103,"leadSponsor":105,"locationsCount":4},"100553558","the-development-and-evaluation-of-sleep-intervention-for-perinatal-family-100553558","NCT06487650","The Development and Evaluation of Sleep Intervention for Perinatal Family","Inclusion Criteria:\n\n1. First-time mothers and their partners aged 20 and older;\n2. Currently 30 weeks gestation or more, singleton;\n3. insomnia severity index score greater than 10;\n4. living with a husband or partner;\n5. Both women and their partners are willing to participate in and adhere to the research protocol;\n6. be able to read and speak the Mandarin language\n\nExclusion Criteria:\n\n1. sleep disorders, depression or anxiety disorders;\n2. medical diseases with abnormal heart rate variability, or arrhythmia;\n3. taking medicines that may affect the autonomic nervous system or\n4. night shift workers;\n5. obstetric complications, including gestational hypertension, preterm labor, labor complications, or postpartum complications;\n6. infants with fetal deformity, or neonatal complications;\n7. no access to Internet resources","ALL","20 Years",{"count":84,"type":21},600,[24],"Background: Sleep disruptions and disturbances are highly prevalent among new mothers and fathers and negatively affect their mental health and infant development outcomes. Effective sleep interventions are vital for family health.\n\nObjectives: To develop a sleep intervention for mother-father-infant triads, and to evaluate the effects on sleep improvement, emotional distress, and infant health outcomes.\n\nMethods: In this proposal, we plan to conduct a parallel-group two-arm randomized controlled trial on pregnant women and their partners. Mother-father-infant triads will be recruited and randomly allocated to the intervention group (receiving a sleep intervention) or the control group. Data will be collected with repeated measures, and the relationship between studied variables will be analyzed with descriptive and inferential statistics.\n\nAnticipatory results: The development and evaluation of an evidence-based sleep intervention will provide a scientific insight into sleep care for pregnant women and their families.",[88,89,28],"Sleep","Psychological Distress",[91,92,93,94,95,96],"sleep quality","perinatal","depression","anxiety","infant sleep","infant health","NOT_YET_RECRUITING","2025-01-12",{"date":100,"type":37},"2025-01-14",{"date":102,"type":21},"2025-12",{"date":104,"type":21},"2026-09",{"name":106,"class":44},"Taipei Medical University"]